{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-092496","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.246664+00:00","generated_at":"2026-05-31T07:48:00.792724+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Traws Pharma receives Nasdaq delisting notice for stockholders' deficit of $105.5M","bullets":["Received Nasdaq letter on Aug 21, 2024 for non-compliance with minimum $2.5M stockholders' equity.","Reported stockholders' deficit of $105.5M as of June 30, 2024, below the required minimum.","Must submit a compliance plan by Oct 7, 2024; extension possible to Feb 18, 2025.","No immediate effect on listing, but failure to regain compliance may lead to delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-092496","json":"https://secwatch.observer/filing/0001104659-24-092496.json","markdown":"https://secwatch.observer/filing/0001104659-24-092496.md","text":"https://secwatch.observer/filing/0001104659-24-092496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924092496/0001104659-24-092496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924092496/tm2422606d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:48:00.792724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}